katie8288Mar 28, 20230 min readPrilenia Archieves Last Patient Visit in Phase 3 PROOF-HD Clinical Study for Huntington's Disease
uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease
PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program
Comments